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Abstract 
 
Context: Autosomal Dominant Polycystic Kidney Disease (ADPKD) is a common 
disorder that can cause hypertension during childhood, but the true prevalence of 
hypertension during childhood is not known. 
 
Objective: We undertook a systematic review and meta-analysis to determine the 
prevalence of hypertension in children with ADPKD. 
 
Data Sources: Systematic review of articles published between 1980-2015 in 
MEDLINE and EMBASE. 
 
Study Selection: Studies selected by 2 authors independently if reporting data on 
prevalence of hypertension in children and young persons aged <21 years with a 
diagnosis of ADPKD. Observational series were included with study populations >15 
children. Articles excluded if inadequate diagnostic criteria for hypertension were used. 
Studies with selection bias were included but analysed separately 
 
Data Extraction: Data extracted on prevalence of hypertension, proteinuria and 
reduced renal function using standardised form. Meta-analysis was performed to 
calculate weighted mean prevalence. 
 
Results: 903 articles were retrieved from our search; 14 studies met the inclusion 
criteria: 1 prospective randomised controlled trial; 8 prospective observational studies; 
and 5 retrospective cross-sectional studies. From 928 children with clinically confirmed 
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ADPKD, 20% [95% CI 15-27%] were hypertensive. The estimated prevalence of 
proteinuria in children with ADPKD is 20% [8 studies; 95% CI 9-40%] while reduced 
renal function occurred in 8% [5 studies; 95% CI 2-26%]. 
 
Limitations: Studies showed a high degree of methodological heterogeneity (𝐼2 =
73.4%, 𝜏2 = 0.3408, p<0.0001). Most studies did not use ABPM to diagnose 
hypertension. 
 
Conclusions: In this meta-analysis we estimate 20% of children with ADPKD have 
hypertension. In the population, many children with ADPKD are not under regular 
follow up and remain undiagnosed. We recommend that all children at risk of ADPKD 
have regular BP measurement. 
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Introduction 
 
Autosomal dominant polycystic kidney disease (ADPKD) is a common genetic disease 
affecting around 1:1000 individuals.[1] Two thirds of patients are hypertensive by the 
age of 30, but most are easily managed with a single antihypertensive agent in the 
early stages. In adults there is evidence that intensive blood pressure control can 
result in favourable clinical endpoints, and untreated hypertension can lead to an 
increased risk of death from cardiovascular causes.[2] There is also evidence in 
children with ADPKD that borderline hypertension can cause an increased left 
ventricular mass,[3] reinforcing the need for good BP control. 
 
There is a lack of consensus with regard to optimal timing of initiation of BP monitoring 
in children with ADPKD. The data that is available on ADPKD symptoms and signs in 
children is limited, but a striking feature is the high prevalence of hypertension with 
several studies reporting between 30-40%.[3–5] The risk of hypertension in children 
with ADPKD is uncertain because there have been a number of different reports with 
varying rates of hypertension, often from relatively small study populations. 
 
The primary aim of this study was to determine the prevalence of hypertension in 
children and young persons with ADPKD, via a systematic review and meta-analysis 
of current literature. Secondary aims were to determine the prevalence of proteinuria, 
an early indicator of disease in many renal conditions, and impaired renal function as 
a later sign of ADPKD progression. 
 
Methods 
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Eligibility Criteria 
 
Studies considered eligible for inclusion in this systematic review were those reporting 
data on the prevalence of hypertension children and young people (<21 years) with a 
confirmed diagnosis of ADPKD. All study designs were considered if they reported 
data on a minimum of 15 children, including retrospective and observational studies. 
Studies were included even if their primary aim was not to establish the prevalence of 
hypertension in children with ADPKD. 
 
Studies were excluded if they did not report specific data on the prevalence of 
hypertension in children with ADPKD. Studies were excluded if they did not report 
adequate diagnostic criteria for ADPKD. Adequate diagnostic criteria would be 
considered as the presence of renal cysts seen on ultrasound with a positive family 
history of ADPKD and/or genetic confirmation of ADPKD. Studies were excluded if 
they were of insufficient methodological quality. Studies were also excluded if they did 
not use an appropriate diagnostic definition for hypertension, according to 
national/international guidance a definition of >95th blood pressure centile for age and 
gender was required (additionally those on treatment for hypertension were classed 
as hypertensive).[6] Studies were excluded if they were duplicate publications or 
clearly contained the same study population as another published study already 
included in this review. Where this was the case the study with the largest number of 
participants was included in this review. Articles not published in English were 
excluded. 
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Information Sources, Search and Study Selection 
 
A systematic search was undertaken searching the MEDLINE and EMBASE 
databases for published articles (excluding any published abstracts) from 1980-2015. 
The search was last conducted in July 2015. The search strategy is in Supplemental 
File 1. 
 
The titles of all papers retrieved from this search were screened by two authors (MM 
and OC) independently for potential inclusion in this review. Potentially relevant 
studies were reviewed (full-text) for inclusion according to the eligibility criteria. Final 
study selection was undertaken by two authors (MM and PW). Reference lists of 
included studies were additionally reviewed for potentially relevant articles. Data 
extracted from studies was included in the meta-analysis. 
 
Data Collection Process and Data Items 
 
Data were collected from included studies using a standardised proforma, piloted by 
one author (MM) and subsequently improved to include data on additional outcomes. 
Data extracted included study year, study setting, number of children with ADPKD, 
study design, primary aim of the study and method of recruitment/selection of children 
into the study (to establish risk of selection bias). Data were also collected on the 
prevalence of hypertension, proteinuria and impaired renal function. Proteinuria was 
defined by the local measurement method but only studies reporting laboratory 
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confirmed proteinuria according to international standards were included in this 
analysis (dipstick confirmation was not accepted). Impaired renal function was taken 
as a GFR (actual or estimated) as <90ml/min/1.73m2. 
 
 
 
Risk of Bias in Included Studies 
 
Although there are many tools which can be used to assess observational studies in 
epidemiology as detailed in the review by Sanderson et al,[7] we are not aware of any 
widely used quality assessment tool for prevalence studies and as different study 
designs were included in this review, we devised a study qualitative evaluation method 
specifically for this review. Included studies were all reviewed in detail and assigned a 
risk of selection bias score (low/moderate/high) as this is one of the main flaws of 
previously published studies reporting the prevalence of hypertension in children with 
ADPKD. Quality markers for each study are defined in Supplementary File 2 and each 
study was ascribed a score of 0-5 based on the presence of these five markers. 
 
 
Summary Measures and Synthesis of Results 
 
The proportion of children with ADPKD who are hypertensive for each study is 
reported, this was combined in a random-effects meta-analysis to obtain a mean 
prevalence for hypertension (with 95% confidence intervals and prediction intervals). 
Prevalence was converted to the logit-scale for data synthesis and back-transformed. 
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Restricted maximum likelihood (REML) was used to estimate the heterogeneity 
variance. Study qualitative evaluation score was not included in the weighting but 
separate meta-analysis has been performed for studies based on the risk of selection 
bias. 
 
 
 
 
 
Risk of Bias across Studies 
 
We assessed the risk of bias across studies by presenting a funnel plot (prevalence 
of hypertension plotted against study size) to determine whether the study data was 
skewed. 
 
Additional Analyses 
 
We analysed whether there was a relationship between prevalence of hypertension 
and prevalence of proteinuria in children with ADPKD at study level. We also analysed 
whether there was a relationship between the mean age of children in a study and 
prevalence of hypertension in the study. 
 
Results are depicted graphically and study-level data analysed using Spearman’s rank 
correlation coefficient to assess for statistical significance. Two-tailed testing was used 
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and a p-value of <0.05 was considered statistically significant. Statistical testing was 
performed using SPSS version 21. 
 
We ran two meta-regression models to test whether there was a relationship between 
prevalence of hypertension and (1) prevalence of proteinuria in children with ADPKD 
and (2) mean age of children at the study level. It was not appropriate to test for an 
association with prevalence of reduced GFR because of the extent of missing data. 
 
Results are depicted graphically using bubble plots. Parameter estimates from the 
meta-regression models, confidence intervals and p-values are presented.  
 
All statistical tests were two-tailed and a p-value of <0.05 was considered statistically 
significant. Statistical analysis was performed using Rstudio (R version 3.2.2), mainly 
using the functions metaprop and metareg (in package meta).  
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Results 
 
Study Selection and Characteristics 
 
The initial search retrieved records for 903 published articles. 90 full text articles were 
retrieved after an initial screen of titles. 29 studies were assessed in detail for potential 
inclusion in this systematic review (Supplementary File 3). 
 
5 studies were excluded because they did not report the proportion of children that 
were hypertensive, or they did not separate this data for children and adults. 3 studies 
were excluded due to insufficient quality or reporting data for <15 children. 7 studies 
were excluded as they were duplicate publications or using the same population of 
children with ADPKD as another included study. 
 
14 studies were eligible for inclusion in this review, Table 1 contains their details. 5 
studies were from the USA, 2 from Canada, 2 from France, 2 from the Czech Republic 
and 1 study each from the UK, Spain and Cyprus. 1 study was a randomised-controlled 
trial, 8 were prospective observational studies while 5 were retrospective cohort or 
cross-sectional studies. None of the studies had the primary aim of determining the 
prevalence of hypertension in children with ADPKD, but only one study had missing 
hypertension data of more than 20% for children included in that study. Only 1 study 
used 24 hour ambulatory BP measurement (ABPM) to diagnose hypertension in all 
children with ADPKD. 
 
Risk of Bias 
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Supplementary File 4 shows a table reporting the risk of selection bias for each study 
and the quality evaluation. Three studies had a high risk of selection bias. The data is 
skewed in the funnel plot (Supplementary File 5) with larger studies reporting a higher 
prevalence of hypertension than smaller studies. This cannot be interpreted as 
publication bias, given that none of the studies have the primary aim of documenting 
the prevalence of hypertension and that we excluded studies not reporting data on 
hypertension, but the skew is noted. All excluded studies which report study 
populations of children with ADPKD but do not include BP data were relatively small. 
 
Primary Outcome 
 
Table 2 shows the results of individual studies. The primary outcome of prevalence of 
hypertension is also depicted in the forest plot in Figure 1 (studies grouped according 
to risk of bias assessment), showing that the weighted mean prevalence of 
hypertension in 928 children with ADPKD is 20% [95%CI 15-27%]. Heterogeneity 
accounted for most of the variation in study prevalence (𝐼2 = 73.4%, 𝜏2 = 0.3408, 
p<0.0001). Given the level of heterogeneity, the prediction interval is much wider than 
the confidence interval [95%PI 6-50%]. 
 
When the three studies with a high risk of selection bias are removed from the analysis, 
the weighted mean prevalence of hypertension in children with ADPKD across 11 
studies (769 children) is virtually unchanged at 20% [95%CI 14-27%] and there is still 
high heterogeneity (𝐼2 = 73.9%, 𝜏2 = 0.3314, p<0.0001). 
Secondary Outcomes 
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The secondary outcomes of prevalence of proteinuria and reduced renal function are 
also shown in Table 2. Forest plots are not depicted but weighted mean prevalence 
has been calculated below. 
 
8 studies (509 children) reported the prevalence of proteinuria in children with ADPKD, 
all studies used an internationally accepted definition of proteinuria (urinary protein 
excretion ≥150mg/day or equivalent value for urine albumin to creatinine ratio or urine 
protein to creatinine ratio) and all measured this in the laboratory (rather than using 
bedside dipstick testing). The mean prevalence of proteinuria in children with ADPKD 
is 20% [95%CI 9-40%]. 
 
5 studies including 226 children reported the prevalence of reduced renal function in 
children with ADPKD, and this was defined as a GFR (actual or estimated) as 
<90ml/min/1.73m2. The mean prevalence of a reduced renal function in children with 
ADPKD is 8% [95%CI 2-26%]. 
 
Additional Analyses 
 
Figure 2 shows the results from a meta-regression of prevalence of hypertension 
against the prevalence of proteinuria, there was no evidence of a relationship in this 
data (slope estimate=-0.013 [95%CI -0.04 to 0.01], p=0.2641). Figure 3 shows the 
results from the meta-regression with mean age of children in a study as a covariate. 
The prevalence of hypertension increases as the mean age in the study increases 
(slope estimate=0.13 [95%CI 0.03 to 0.22], p=0.0128).  
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Discussion 
This systematic review and meta-analysis estimated the mean prevalence of 
hypertension is 20% [95%CI 15-27%] from 928 children and young persons with 
ADPKD and 14 studies reported over the past two decades. Even when the studies 
with a high risk of selection bias were removed from the analysis, the same figure of 
20% prevalence of hypertension was found. The pathophysiology of hypertension in 
ADPKD is complex and not fully understood,[8–10] but it is well-recognised that there 
can be hypertension in the absence of other signs such as proteinuria and reduced 
renal function. These observations were confirmed in children here - 20% had 
proteinuria but Figure 2 demonstrates the lack of a relationship with the prevalence of 
hypertension at study level. Unfortunately, individual patient data was not available 
from enough studies to investigate this further, but this is perhaps unsurprising given 
that the link between proteinuria and onset of renal dysfunction comes mainly from 
diffuse glomerular and tubulointerstital diseases, rather than the patchy cystic 
dilatation and expansion seen in ADPKD. Similarly, only 8% of children were reported 
to have reduced GFR.  
 
One of the major criticisms of individual studies reporting the prevalence of 
hypertension in ADPKD is that they might reflect highly selected populations, derived 
from children referred to tertiary and specialist centres. These are likely to contain a 
higher proportion of symptomatic children and ‘fast-progressors’. We recognise that 
some such reports are included in this meta-analysis but they were combined with all 
other available studies to generate the best current prevalence estimate at 20%, with 
little change when data were reanalysed without three studies with a high risk of 
selection bias, which suggests that our concerns may be unfounded. 
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There are limitations to this analysis, the most prominent being that none of the 14 
included studies had the primary aim of reporting the prevalence of hypertension in 
children with ADPKD, therefore their study design was not optimised to estimate 
prevalence of hypertension in children with ADPKD. Although this reduces the risk of 
publication bias, it does mean that other biases would not have been accounted for in 
the original study designs. There was also a high degree of heterogeneity between the 
studies, which results in wide confidence and prediction intervals. In addition, we 
excluded several repeated studies from specific centres which clearly built up their 
cohort sizes over time but still included children that had been counted in earlier 
studies. There is a small risk, in excluding these studies, that we failed to include some 
children and therefore reduced our sample of studies. Furthermore, by using the mean 
as a best estimate of prevalence, we assume the samples of children with ADPKD in 
each study are representative of the population outside of a study setting. 
 
Bearing in mind that two thirds of ADPKD patients are hypertensive by the age of 30 
whereas we found 20% prevalence in children and young people, we performed 
further analysis from our studies to see if there appeared to be an increased risk with 
age (Figure 3). Using meta-regression we found that as the mean age in the study 
increased, the prevalence of hypertension increased. This is in agreement with adult 
knowledge where there is an increasing prevalence of hypertension with increasing 
age. 
 
It is notable that only one of the included studies used ABPM to assess blood pressure 
in children. This is standard practice for diagnosing early hypertension in adults in 
many countries; in the UK, for example, the National Institute for Clinical Excellence 
15 
 
(NICE) guidelines suggest that clinic BP levels around 140/90 should be confirmed by 
ABPM or regular home BP before starting therapy.[11] It could be argued that 
hypertension cannot be truly excluded through clinic BP measurement in children with 
ADPKD, ABPM measurement should be performed to exclude hypertension. This 
raises the possibility that our estimate of 20% is an underestimate because the 
included studies may have underdiagnosed ‘borderline hypertension’. In the one study 
which performed ABPM for all 62 included children, 22 were deemed hypertensive in 
this study but out of these 10 children had isolated nocturnal hypertension which would 
not have been identified had ABPM not been used.[5] Therefore there is a risk that a 
large proportion of hypertensive children with ADPKD are not being identified under 
the current regimen and ABPM should be considered for future practice. In addition, a 
number of the studies included in our review note the increased risk of left ventricular 
hypertrophy in children with ADPKD which is clearly related to hypertension, and 
provides further evidence that hypertension in children with ADPKD can have 
significant health effects.[3], [12] 
 
In conclusion, this systematic review and meta-analysis estimates a 20% prevalence 
of hypertension in children and young persons with ADPKD, calling into question the 
belief that some clinicians still hold about ADPKD being an ‘adult’ disease. In light of 
these results we recommend that all adults diagnosed with ADPKD should be asked 
about their children and offered advice and support in deciding on the medical 
management of their entire family. We also recommend that all children with confirmed 
ADPKD or are at risk of ADPKD should have annual blood pressure checks and urine 
albumin: creatinine ratio measurement to ensure timely diagnosis of any 
complications. Further prospective research is required to more carefully evaluate BP 
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in children with ADPKD, including ABPM to detect ‘borderline hypertension’ and 
measures of target organ damage such as cardiac and vascular assessment to detect 
early complications of undiagnosed hypertension in children with ADPKD. The 
formation of ADPKD registries and the adoption of this condition to established 
registries such as the UK National Registry of rare kidney diseases (RaDaR) will 
hopefully facilitate further prospective multi-centre studies to investigate hypertension 
in children with ADPKD.  
17 
 
“What is already known on this topic” 
 ADPKD is a common disorder which often remains undiagnosed in childhood 
 Children with ADPKD can develop hypertension 
 
 “What this study adds” 
 Hypertension is common in ADPKD, affecting up to a quarter of children with ADPKD 
 All children with confirmed ADPKD, or at risk of ADPKD, should have regular blood 
pressure monitoring during childhood 
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Table 1 
 
Characteristics of 14 studies included in this systematic review. 
 
 
Study Mean 
Age in 
Study 
(years) 
Main Aim of Study Study 
Design 
Study Recruitment 
Boyer et al. 
2007[13] 
4.9 To study the prognosis of 
children diagnosed with ADPKD 
in-utero or at birth 
Retrospecti
ve cross-
sectional 
Consecutive recruitment of 
selected group of children with 
ADPKD 
Cadnapaphornchai 
et al. 2008[3] 
12.8 To assess the clinical 
manifestations of ADPKD in 
children, related to blood 
pressure 
Prospective 
observation
al 
Unclear, children with ADPKD 
and normal renal function were 
eligible 
Cadnapaphornchai 
et al. 2014[14] 
16 To assess the effect of 
pravastatin on kidney structure 
and size in children with ADPKD 
Randomise
d controlled 
trial 
Unclear, all children in this study 
were already receiving lisinopril 
Demetriou et al. 
2000[15] 
Not 
reporte
d 
To assess disease and 
symptoms in individuals with an 
PKD2 mutation 
Prospective 
observation
al 
Participants recruited from 
families known to have the 
PKD2 mutation 
Fencl et al. 
2009[16] 
8.7 To compare clinical features of 
ADPKD in those with a PKD1 
and PKD2 mutation 
Retrospecti
ve cross-
sectional 
Retrospective, included all 
children with a known PKD1 or 
PKD2 mutation 
Ivy et al. 1995[12] 9.6 To determine the cardiovascular 
manifestations of ADPKD in 
children 
Prospective 
observation
al 
Children of parents with ADPKD 
consecutively recruited, children 
with confirmed ADPKD analysed 
Mekahli et al. 
2010[17] 
12.9 To compare the manifestations 
of ADPKD presenting by 
screening or with symptoms 
Retrospecti
ve cross-
sectional 
Retrospective review of all 
patients on a database with 
ADPKD 
Nicolau et al. 
2000[18] 
Not 
reporte
d 
To determine whether kidney 
size is related to other 
manifestations of ADPKD 
Prospective 
observation
al 
Participants at risk of ADPKD 
consecutively recruited, the 
those with positive diagnosis 
analysed 
Reed et al. 
2010[19] 
Not 
reporte
d 
To update diagnostic criteria by 
ultrasound for children with 
ADPKD 
Retrospecti
ve cohort 
study 
Retrospectively included all 
children at risk of ADPKD, 
confirmed diagnoses analysed 
Seeman et al. 
2003[5] 
12.3 To determine if blood pressure 
is related to kidney size in 
ADPKD 
Prospective 
observation
al 
Unclear whether consecutive 
recruitment, children seen at 
one centre 
Selistre et al. 
2012[20] 
10 To evaluate the prevalence and 
severity of early renal 
dysfunction in ADPKD 
Prospective 
observation
al 
All children with ADPKD referred 
to one centre were 
consecutively recruited 
Shamshirsaz et al. 
2005[4] 
13.3 To determine the progression 
and outcome of early onset 
ADPKD in children 
Prospective 
observation
al 
All children referred to a centre 
or with parents with ADPKD 
were consecutively recruited 
Tee et al. 2004[21] 8.7 To determine the phenotypic 
characteristics of ADPKD in 
children 
Retrospecti
ve cross-
sectional 
All children seen at a single 
centre over 20 years with 
ADPKD 
Wong et al. 
2004[22] 
9.8 To assess the presence of 
glomerular hyperfiltration in 
children with ADPKD 
Prospective 
observation
al 
All children with ADPKD but not 
on therapy during a 1 year 
period were eligible 
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Table 2 
 
Outcome data for 14 studies included in this systematic review. 
 
 
Study Number of 
children 
that are 
hypertensiv
e 
% of 
children 
hypertensiv
e 
Number of 
children 
with 
proteinuria 
% of 
children 
with 
proteinuria 
Number of 
children 
with 
reduced 
GFR 
% of 
children 
with 
reduced 
GFR 
Boyer et al. 2007 5/26 19% 2/26 8% 2/26 8% 
Cadnapaphornchai 
et al. 2008 
28/85 33%     
Cadnapaphornchai 
et al. 2014 
40/110 36%     
Demetriou et al. 
2000 
0/23 0%     
Fencl et al. 2009 12/60 22% 24/50 48% 1/60 2% 
Ivy et al. 1995 11/83 13%     
Mekahli et al. 2010 7/47 15% 17/47 36% 13/33 39% 
Nicolau et al. 2000 3/41 7%     
Reed et al. 2010 15/67 22%     
Seeman et al. 
2003 
22/62 35% 2/62 3%   
Selistre et al. 2012 3/52 6% 30/52 58% 6/52 12% 
Shamshirsaz et al. 
2005 
64/199 32% 73/199 37%   
Tee et al. 2004 12/55 22% 4/55 7% 1/55 2% 
Wong et al. 2004 0/18 0% 1/18 6%   
 
Hypertension – defined as blood pressure >95th centile for age and gender. 
Reduced GFR (glomerular filtration rate) – defined as a GFR (estimated or 
measured) <90ml/min. 
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Figure Legends 
 
Figure 1 
Forest plot for the primary outcome of prevalence of hypertension in children with 
ADPKD, grouped according to risk of bias assessment. 
 
Figure 2 
Meta-regression graph showing prevalence of proteinuria vs. prevalence of 
hypertension across 8 studies reporting both outcomes (study-level data). 
Footnotes to Figure 2: 
Size of bubble corresponds to study size. 
No evidence of a significant relationship (p=0.26). 
 
Figure 3 
Meta-regression graph showing mean age vs. prevalence of hypertension across 11 
studies reporting both (study-level data). 
Footnotes to Figure 3: 
Size of bubble corresponds to study size. 
Prevalence of hypertension increases with mean age in the study (p=0.01). 
 
 
 
 
 
 
 
